✦ LIBER ✦

Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy

✍ Scribed by Peter Ferenci; Thomas–Matthias Scherzer; Heidrun Kerschner; Karoline Rutter; Sandra Beinhardt; Harald Hofer; Maximilian Schöniger–Hekele; Heidemarie Holzmann; Petra Steindl–Munda

Book ID: 119760562
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 591 KB
Volume: 135
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2008.07.072

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

63 SILIBININ IS A POTENT ANTIVIRAL AGENT

63 SILIBININ IS A POTENT ANTIVIRAL AGENT IN PATIENTS WITH CHRONIC HEPATITIS C NOT RESPONDING TO ANTIVIRAL COMBINATION THERAPY

✍ P. Ferenci; T.M. Scherzer; H. Hofer; M. Sch¨oniger-Hekele; P. Steindl-Munda 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

W1002 Silibinin Is a Potent Antiviral Ag

W1002 Silibinin Is a Potent Antiviral Agent in Patients with Chronic HCV Infection Not Responding to Peginterferon/Ribavirin Therapy

✍ Scherzer, Thomas-Matthias; Hofer, Harald; Schoeniger-Hekele, Maximilian; Steindl 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Treatment with amantadine +ribavirin +in

Treatment with amantadine +ribavirin +interferon in patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy

✍ Ferenci, Peter; Stauber, Rudolf; Hackl, Franz; Schuetze, Kurt; Bauer, Bernhard; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Retreatment with pegylated interferon-al

Retreatment with pegylated interferon-alpha2b plus ribavirin in patients with chronic hepatitis C not responding to a previous antiviral treatment with standard interferons combined with ribavirin

✍ Teuber, Gerlinde; Kallinowski, Birgit; Niederau, Claus; Klinker, Hans; Galle, Pe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Ribavirin and alpha-interferon in patien

Ribavirin and alpha-interferon in patients with chronic hepatitis C not responding to interferon alone

✍ S. Tripi; G. Di Gaetano; F. Cartabellotta; R. Vassallo; M. Soresi; A. Carroccio; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Controlled trial with pegylated interfer

Controlled trial with pegylated interferon-alpha2b plus ribavirin retreatment in patients with chronic hepatitis C not responding to a previous antiviral treatment with standard interferons combined with ribavirin

✍ G. Teuber; B. Kallinowski; C. Niederau; H. Klinker; P.R. Galle; M. Zankel; S. Ze 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB